We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$668B
AUM Growth
+$46.4B
Cap. Flow
-$7.16B
Cap. Flow %
-1.07%
Top 10 Hldgs %
28.47%
Holding
3,020
New
65
Increased
1,711
Reduced
924
Closed
98

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.58B
2
TMUS icon
T-Mobile US
TMUS
+$1.53B
3
MS icon
Morgan Stanley
MS
+$1.15B
4
META icon
Meta Platforms (Facebook)
META
+$1.15B
5
AAPL icon
Apple
AAPL
+$1.14B

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.94B
2
AMZN icon
Amazon
AMZN
+$2.82B
3
GE icon
GE Aerospace
GE
+$1.93B
4
GS icon
Goldman Sachs
GS
+$1.88B
5
NOW icon
ServiceNow
NOW
+$1.28B

Sector Composition

Rank Sector Weight
1 Technology 30.25%
2 Healthcare 17.75%
3 Financials 11.32%
4 Consumer Discretionary 11.17%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEUE
2876
DELISTED
NeueHealth
NEUE
$9K ﹤0.01%
457
-2,196
-83% -$113K
BODI icon
2877
The Beachbody Company
BODI
$45.6M
$9K ﹤0.01%
342
PDYN icon
2878
Palladyne AI
PDYN
$312M
$9K ﹤0.01%
2,842
UTAAW
2879
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$9K ﹤0.01%
36,750
AIM
2880
AIM ImmunoTech
AIM
$7.19M
$9K ﹤0.01%
203
-955
-82% -$49.5K
TIL icon
2881
Instil Bio
TIL
$49.7M
$8K ﹤0.01%
555
TONX
2882
TON Strategy Co
TONX
$161M
$8K ﹤0.01%
7
NETC.WS
2883
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$8K ﹤0.01%
38,375
AHRNW
2884
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
$8K ﹤0.01%
55,000
CELU icon
2885
Celularity
CELU
$20.3M
$7K ﹤0.01%
1,120
AIRJW
2886
AirJoule Technologies Warrant
AIRJW
$96.4M
$7K ﹤0.01%
56,154
-1
-0%
BBBY
2887
DELISTED
Bed Bath & Beyond Inc
BBBY
$7K ﹤0.01%
14,325
-27,407
-66% -$56.5K
BFAC.WS
2888
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$6K ﹤0.01%
55,855
GRNA
2889
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$6K ﹤0.01%
13,492
SCUA.WS
2890
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$6K ﹤0.01%
55,000
BOAC.WS
2891
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$6K ﹤0.01%
46,500
VTGN icon
2892
VistaGen Therapeutics
VTGN
$11.7M
$5K ﹤0.01%
1,132
WGSWW
2893
DELISTED
GeneDx Holdings Warrant
WGSWW
$5K ﹤0.01%
265,426
-14,768
-5% -$351
GCTS.WS
2894
GCT Semiconductor Holding Warrants
GCTS.WS
$18.9M
$5K ﹤0.01%
37,675
ONYXW
2895
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$5K ﹤0.01%
37,750
SOAR.WS
2896
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$5K ﹤0.01%
55,375
CMCAW
2897
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$5K ﹤0.01%
55,375
NBIS
2898
Nebius Group N.V.
NBIS
$68.5B
$4K ﹤0.01%
5,602,969
-696
-0%
HLGN
2899
DELISTED
Heliogen, Inc.
HLGN
$4K ﹤0.01%
401
MTEM
2900
DELISTED
Molecular Templates, Inc.
MTEM
$4K ﹤0.01%
667

Similar funds

T. Rowe Price Associates's Q1 2023 Portfolio in Review

As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
  • T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
  • T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
  • T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
  • T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
  • T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.

Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.